Low-Dose Ketamine Pretreatment Reduces the Incidence and Severity of Myoclonus Induced by Etomidate: A Randomized, Double-Blinded, Controlled Clinical Trial

Guan-Nan Wu, Hai-Jun Xu, Fang-Fang Liu, Xian Wu, Hai Zhou, Guan-Nan Wu, Hai-Jun Xu, Fang-Fang Liu, Xian Wu, Hai Zhou

Abstract

Myoclonic movement induced by etomidate is a common but undesirable problem during general anesthesia induction. To investigate the influence of pretreatment with low-dose ketamine on the incidence and severity of myoclonus induced by etomidate, 104 patients were randomized allocated to 1 of 2 equally sized groups (n = 52) to receive either intravenous low-dose ketamine 0.5 mg/kg (group K) or an equal volume of normal saline (group S) 1 minute before induction of anesthesia with 0.3-mg/kg etomidate. The incidence and severity of myoclonus were assessed for 2 minutes after administration of etomidate. Here, we found that the incidence and intensity of myoclonus were both significantly reduced in low-dose ketamine-treated group compared with saline-treated group. The incidence of adverse effects was low and similar between groups. These results demonstrate that intravenous infusion of low-dose ketamine 0.5 mg/kg 1 minute prior to etomidate administration is effective in relieving etomidate-induced myoclonic movements during general anesthesia induction.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Patient flow (according to the consort chart). Group K = ketamine group, group S = saline group.

References

    1. Erdoes G, Basciani RM, Eberle B. Etomidate: a review of robust evidence for its use in various clinical scenarios. Acta Anaesthesiol Scand 2014; 58:380–389.
    1. Doenicke A, Roizen MF, Nebauer AE, et al. A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol. Anesth Analg 1994; 79:933–939.
    1. Doenicke AW, Roizen MF, Kugler J, et al. Reducing myoclonus after etomidate. Anesthesiology 1999; 90:113–119.
    1. Berry JM, Merin RG. Etomidate myoclonus and the open globe. Anesth Analg 1989; 69:256–259.
    1. Grant IS, Hutchison G. Epileptiform seizures during prolonged etomidate sedation. Lancet (London, England) 1983; 2:511–512.
    1. Reddy RV, Moorthy SS, Dierdorf SF, et al. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg 1993; 77:1008–1011.
    1. Voss LJ, Sleigh JW, Barnard JP, et al. The howling cortex: seizures and general anesthetic drugs. Anesth Analg 2008; 107:1689–1703.
    1. Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure 2015; 30:14–20.
    1. Kolesnikov Y, Jain S, Wilson R, et al. Blockade of morphine-induced hindlimb myoclonic seizures in mice by ketamine. Pharmacol Biochem Behav 1997; 56:423–425.
    1. Forero M, Chan PS, Restrepo-Garces CE. Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine infusion. Pain Pract 2012; 12:154–158.
    1. Wagner RL, White PF, Kan PB, et al. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984; 310:1415–1421.
    1. Morgan M, Lumley J, Whitwam JG. Etomidate, a new water-soluble non-barbiturate intravenous induction agent. Lancet (London, England) 1975; 1:955–956.
    1. Kay B. A dose-response relationship for etomidate, with some observations on cumulation. Br J Anaesth 1976; 48:213–216.
    1. Harris CE, Murray AM, Anderson JM, et al. Effects of thiopentone, etomidate and propofol on the haemodynamic response to tracheal intubation. Anaesthesia 1988; 43:32–36.
    1. Moss E, Powell D, Gibson RM, et al. Effect of etomidate on intracranial pressure and cerebral perfusion pressure. Br J Anaesth 1979; 51:347–352.
    1. Stockham RJ, Stanley TH, Pace NL, et al. Fentanyl pretreatment modifies anaesthetic induction with etomidate. Anaesth Intensive Care 1988; 16:171–176.
    1. Hueter L, Schwarzkopf K, Simon M, et al. Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand 2003; 47:482–484.
    1. Ri HS, Shin SW, Kim TK, et al. The proper effect site concentration of remifentanil for prevention of myoclonus after etomidate injection. Korean J Anesthesiol 2011; 61:127–132.
    1. Huter L, Schreiber T, Gugel M, et al. Low-dose intravenous midazolam reduces etomidate-induced myoclonus: a prospective, randomized study in patients undergoing elective cardioversion. Anesth Analg 2007; 105:1298–1302.
    1. Choi JM, Choi IC, Jeong YB, et al. Pretreatment of rocuronium reduces the frequency and severity of etomidate-induced myoclonus. J Clin Anesth 2008; 20:601–604.
    1. Gultop F, Akkaya T, Bedirli N, et al. Lidocaine pretreatment reduces the frequency and severity of myoclonus induced by etomidate. J Anesth 2010; 24:300–302.
    1. Mizrak A, Koruk S, Bilgi M, et al. Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double-blind controlled trial. J Surg Res 2010; 159:e11–e16.
    1. Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacol Rev 1999; 51:7–61.
    1. Freeman FG, Jarvis MF, Duncan PM. Phencyclidine raises kindled seizure thresholds. Pharmacol Biochem Behav 1982; 16:1009–1011.
    1. Aram JA, Martin D, Tomczyk M, et al. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J Pharmacol Exp Ther 1989; 248:320–328.
    1. Reuben SS, Buvanendran A. Preventing the development of chronic pain after orthopaedic surgery with preventive multimodal analgesic techniques. J Bone Joint Surg Am 2007; 89:1343–1358.
    1. Topcuoglu PT, Uzun S, Canbay O, et al. Ketamine, but not priming, improves intubating conditions during a propofol-rocuronium induction. Can J Anaesth 2010; 57:113–119.
    1. Kaur S, Saroa R, Aggarwal S. Effect of intraoperative infusion of low-dose ketamine on management of postoperative analgesia. J Nat Sci Biol Med 2015; 6:378–382.
    1. Lin TY, Lee WC, Wu CY. Low-dose ketamine for analgesia in the ED: a retrospective case series. Am J Emerg Med 2011; 29:348.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다